Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- L-arginine in Treatment as Usual in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of L-arginine in Treatment as Usual in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00718510).
- L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: Complete Statistical AnalysisIndependent statistical analysis of L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01733407).
- L-ThyroxineIndependent statistical analysis of Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06660823).
- L12-078Independent statistical analysis of Pain Control With Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01680549).
- La ComunidadIndependent statistical analysis of Latinos Combating Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01831921).
- LA-CEAL 4.0: Wearable Sensor Project: Complete Statistical AnalysisIndependent statistical analysis of LA-CEAL 4.0: Wearable Sensor Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06086028).
- Lab Evaluation of Novel Hearing Aid Coupling Method: Complete Statistical AnalysisIndependent statistical analysis of Lab Evaluation of Novel Hearing Aid Coupling Method: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05377359).
- Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114971).
- Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana: Complete Statistical AnalysisIndependent statistical analysis of Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01844687).
- Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LABYRIndependent statistical analysis of Wayfinding Intervention in High-Fidelity Long-Term Memory: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04253587).
- LACLOTIndependent statistical analysis of Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LADHSIndependent statistical analysis of Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05535777).
- LADIIIndependent statistical analysis of Labor and Delivery Implant Insertion: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02866643).
- LAG-3/IMP321Independent statistical analysis of Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01308294).
- LAGB as a Treatment for Morbid Obesity in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of LAGB as a Treatment for Morbid Obesity in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01045499).
- LAIVIndependent statistical analysis of A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- LAL1610Independent statistical analysis of Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation: Complete Statistical AnalysisIndependent statistical analysis of Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Lamotrigine 25 mg Chewable Tablets, Non-Fasting: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine 25 mg Chewable Tablets, Non-Fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00838136).
- Lamotrigine Bioequivalence: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Bioequivalence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01995825).
- Lamotrigine Extended-Release In Elderly Patients With Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Extended-Release In Elderly Patients With Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00516139).
- Lamotrigine Monotherapy in Pediatric Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Monotherapy in Pediatric Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00176228).
- Lamotrigine Pregnancy Registry (LAM05): Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Pregnancy Registry (LAM05): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01064297).
- LAMPIndependent statistical analysis of Learning to Apply Mindfulness to Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04526158).
- LANAPIndependent statistical analysis of Study to Compare Laser Assisted New Attachment Procedure (LANAP) to Traditional Treatments of Chronic Periodontitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients: Complete Statistical AnalysisIndependent statistical analysis of Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383708).
- Lanreotide in the Treatment of Small Bowel Motility Disorders: Complete Statistical AnalysisIndependent statistical analysis of Lanreotide in the Treatment of Small Bowel Motility Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03012594).
- LANTERNIndependent statistical analysis of Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly: primary endpoint results, effect estimate with confidence interval,…
- Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases: Complete Statistical AnalysisIndependent statistical analysis of Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01944930).
- Laparoscopic TAP Block for Sleeve Gastrectomy: Does Timing Matter: Complete Statistical AnalysisIndependent statistical analysis of Laparoscopic TAP Block for Sleeve Gastrectomy: Does Timing Matter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04787367).
- Laparoscopic Versus Open Appendectomy? Let the Patient Decide: Complete Statistical AnalysisIndependent statistical analysis of Laparoscopic Versus Open Appendectomy? Let the Patient Decide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01738750).
- Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen: primary endpoint results, effect estimate with confidence interval,…
- Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ): Complete Statistical AnalysisIndependent statistical analysis of Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LapBand Adjustment to Improve Early Weight Loss: Complete Statistical AnalysisIndependent statistical analysis of LapBand Adjustment to Improve Early Weight Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01060592).
- LAPISIndependent statistical analysis of Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer:…
- LaPPSIndependent statistical analysis of LaPPS: Labor Podcast for Patient Satisfaction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04933708).
- LAPTOPIndependent statistical analysis of The Late Presenter Treatment Optimisation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03696160).
- LARIndependent statistical analysis of Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00929669).
- LARDIndependent statistical analysis of Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756730).
- Large Head X3 Study: Complete Statistical AnalysisIndependent statistical analysis of Large Head X3 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02543437).